XML 78 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Investments in Other Entities - Summarized Balance Sheets and Statements of Income (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Assets                
Cash and cash equivalents $ 234,223   $ 234,223     $ 233,097   $ 193,470
Receivables, net 67,263   67,263     10,608    
Loan receivable 0   0     4,000    
Total assets [1] 951,064   951,064     852,363    
Liabilities and Stockholders’ Deficit                
Current liabilities 185,238   185,238     115,371    
Stockholders’ deficit 485,845 $ 404,582 485,845 $ 404,582 $ 479,521 460,490 $ 349,687 $ 330,911
Total liabilities, mezzanine equity, and stockholders’ equity 951,064   951,064     852,363    
Statement of Operations                
Revenue 269,697 175,638 532,954 351,696        
Expenses 254,315 154,650 491,360 308,926        
Income (loss) from operations 15,382 20,988 41,594 42,770        
Other loss 3,034 (15,883) 3,647 (14,579)        
Net income 10,591 $ 59,530 22,664 73,988        
LaSalle Medical Associates                
Assets                
Cash and cash equivalents 16,250   16,250     6,619    
Restricted cash 698   698     696    
Receivables, net 5,516   5,516     2,269    
Loan receivable 2,250   2,250     2,250    
Total assets 24,714   24,714     11,834    
Liabilities and Stockholders’ Deficit                
Current liabilities 35,266   35,266     32,405    
Stockholders’ deficit (10,552)   (10,552)     (20,571)    
Total liabilities, mezzanine equity, and stockholders’ equity $ 24,714   24,714     $ 11,834    
Statement of Operations                
Revenue     126,067 95,212        
Expenses     121,406 104,570        
Income (loss) from operations     4,661 (9,358)        
Other loss     (58) 0        
Net income     $ 4,603 $ (9,358)        
[1] The Company’s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company’s consolidated VIEs totaling $599.7 million and $567.0 million as of June 30, 2022 and December 31, 2021, respectively, and total liabilities of the Company’s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $143.7 million and $91.7 million as of June 30, 2022 and December 31, 2021, respectively. The VIE balances do not include $431.3 million of investment in affiliates and $36.0 million of amounts due from affiliates as of June 30, 2022 and $802.8 million of investment in affiliates and $6.6 million of amounts due from affiliates as of December 31, 2021 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 16 – “Variable Interest Entities (VIEs)” for further detail.